STAT6: A transcriptional regulatory hub mediating direct repression of inflammatory enhancers and restriction of selective macrophage polarization

This article systematically elucidates the inhibitory function of STAT6 transcription factor activated by interleukin-4 in alternative polarization of macrophages, elaborating its molecular mechanisms through direct transcriptional repression of a large number of genes, reduction of lineage-determining transcription factor binding with p300 and RNA polymerase II, and consequently decreased enhancer RNA expression and chromatin accessibility; analyzes the role of HDAC3 in STAT6 repressor function and its overlapping relationship with the NF-κB p65 enhancer landscape; and explores how this inhibitory epigenomic signature limits macrophage responsiveness to inflammatory stimuli and reduces pyroptosis.

  • Recent Advances
  • Product Information
Recent Advances

 

STAT6: A Transcriptional Regulatory Hub Mediating Direct Repression by Inflammatory Enhancers and Restriction of Selective Macrophage Polarization
Summary: This article focuses on the repressive function of the interleukin-4-activated STAT6 transcription factor in alternative macrophage polarization, systematically elaborating its molecular mechanism of directly transcriptionally repressing a large number of genes, reducing the binding of lineage-determining transcription factors and p300 and RNA polymerase II, and thereby decreasing enhancer RNA expression and chromatin accessibility. It analyzes the role of HDAC3 in the repressor function of STAT6 and its overlap with the NF-κB p65 enhancer landscape, and discusses how this repressive epigenomic signature limits the responsiveness of macrophages to inflammatory stimuli and reduces pyroptosis.
I. The overlooked repressive regulatory dimension in macrophage polarization research.
The molecular basis of signal-dependent transcriptional activation has been extensively studied in macrophage polarization, but our understanding of the molecular determinants of repression remains limited. This cognitive asymmetry constitutes the starting point of this study——previous research has mostly focused on how transcription factors “turn on” gene expression programs, while systematic understanding of how they actively “turn off” another set of programs, especially in the classic model of macrophage polarization, remains insufficient. From the perspective of macrophage biology, this gap is of substantive significance: alternative polarization not only means upregulation of M2-related genes, but also means active repression of pro-inflammatory gene programs. If only the activation side is focused on while the repression side is ignored, the understanding of the polarization state will be incomplete.
II. Functional positioning of STAT6 as a direct transcriptional repressor.
Here, the study shows that the IL-4-activated STAT6 transcription factor is required for direct transcriptional repression of a large number of genes during alternative macrophage polarization in vitro and in vivo. This finding redefines the functional boundaries of STAT6——it is not merely a transcriptional activator, but a key regulatory molecule that simultaneously undertakes direct transcriptional repression. Mechanistically, after being activated by IL-4, STAT6, in addition to binding and activating M2 signature genes, also directly binds to the regulatory regions of a large number of repressed genes and initiates an active repression program. This “activation-repression” dual function makes STAT6 a bidirectional executor of gene expression reprogramming during alternative polarization.
III. The chromatin and transcriptional cascade of STAT6-mediated repression.
Repression leads to reduced binding of lineage-determining transcription factors, p300, and RNA polymerase II, followed by decreased enhancer RNA expression, reduced H3K27 acetylation, and decreased chromatin accessibility. This cascade can be summarized as four levels: “reduced transcription factor binding—dissociation of coactivators and polymerase—decline in enhancer activity—chromatin closure.” Among these, p300, as a histone acetyltransferase, directly leads to a decrease in H3K27 acetylation levels when its binding is reduced; H3K27 acetylation is a hallmark modification of active enhancers, and its reduction means that enhancers transition from an active state to a closed state; the decrease in enhancer RNA expression is direct transcriptomic evidence of reduced enhancer activity; and the reduction in chromatin accessibility physically reflects the closure of regulatory regions. The evidence at these four levels corroborates one another and jointly constitutes the complete molecular chain of STAT6-mediated repression.
IV. HDAC3 dependence and overlap with the NF-κB enhancer landscape.
The repressor function of STAT6 is HDAC3-dependent for a subset of IL-4-repressed genes. This indicates that the repression mechanism of STAT6 is not a single pathway, but includes both HDAC3-dependent and -independent modes, with the former further consolidating the closed state of chromatin through histone deacetylase activity. In addition, enhancers repressed by STAT6 extensively overlap with the NF-κB p65 cistrome and, after IL-4 stimulation of a subset of genes, exhibit reduced responsiveness to lipopolysaccharide. This overlap has important functional implications: the enhancers repressed by STAT6 are precisely the major regions where NF-κB p65 exerts activating effects under inflammatory stimulation. Therefore, the repressive effect of STAT6 essentially “pre-occupies” or “closes” the action sites of pro-inflammatory transcription factors at the enhancer level, thereby preventing macrophages from effectively initiating inflammatory gene programs upon subsequent exposure to lipopolysaccharide stimulation.
V. Functional consequences of the repressive epigenomic signature for inflammatory responsiveness.
Consequently, macrophages exhibit reduced inflammasome activation, decreased IL-1β production, and pyroptosis. Thus, the IL-4-STAT6 signaling pathway establishes another polarization-specific epigenomic signature that leads to attenuated responsiveness of macrophages to inflammatory stimuli. The interpretation of this functional consequence can be understood from the perspective of epigenetic memory: IL-4 stimulation not only changes the gene expression profile at the moment, but also leaves a lasting “imprint” on macrophages through changes in chromatin modifications, enabling them to maintain a lower response capacity under subsequent inflammatory stimulation. This “trained immunity”-style epigenetic reprogramming functionally distinguishes alternatively polarized macrophages from resting macrophages and provides a molecular basis for their roles in inflammation resolution and tissue repair.
VI. Conclusion.
STAT6, as an IL-4-activated transcription factor, has become an important hub connecting transcriptional regulation, epigenetic remodeling, and functional polarization of macrophages, by virtue of its direct transcriptional repression of a large number of genes during alternative macrophage polarization, its four-level cascade mechanism of reducing enhancer RNA expression and H3K27 acetylation and chromatin accessibility through decreasing the binding of lineage-determining transcription factors with p300 and RNA polymerase II, its repressor function that is partially dependent on HDAC3, and the reduced responsiveness to lipopolysaccharide resulting from the extensive overlap of its repressed enhancers with the NF-κB p65 landscape.
VII. Common questions about STAT6 binding activity detection and product information
To facilitate the retrieval of evaluation schemes and product information for STAT6 interactions by researchers and drug development teams, this section answers common questions about STAT6 binding activity detection in a Q&A format and provides the product positioning and applicable scenarios of STAT6 GST Tag Protein, Human.
Q1: What methods are used to detect the binding activity of STAT6?
The functional core of STAT6 lies in the recognition of phosphorylated receptor peptides by its SH2 domain, followed by dimerization and DNA binding. Currently, in vitro methods for evaluating the interaction between STAT6 and phosphorylated receptor peptides, or for evaluating candidate molecules that block this interaction, mainly include enzyme-linked immunosorbent assay (ELISA), surface plasmon resonance (SPR) and biolayer interferometry (BLI), and time-resolved fluorescence resonance energy transfer (TR-FRET). Among these, TR-FRET can complete the binding reaction in a homogeneous solution without coating and washing steps, and can directly read the energy transfer signal between donor and acceptor, making it suitable for quantitative analysis and high-throughput screening of the binding activity between STAT6 and phosphorylated peptides.
Q2: How does TR-FRET reflect the activity of STAT6 inhibitors?
In the TR-FRET system, donor and acceptor fluorophores are labeled on the STAT6 protein and phosphorylated receptor peptide, respectively. When the two bind, the distance shortens and an energy transfer signal is generated. After adding small-molecule inhibitors or blocking antibodies targeting the STAT6 SH2 domain, the candidate molecules competitively occupy the binding interface of the SH2 domain, the complexes formed decrease, and the TR-FRET signal decreases with increasing inhibitor concentration; by plotting the signal inhibition rate against the candidate molecule concentration, the half-maximal inhibitory concentration (IC50) can be fitted to compare inhibitory capacity and rank candidate molecules.
Q3: What is STAT6 GST Tag Protein, Human?
STAT6 GST Tag Protein, Human (Catalog No. UA085028) is a human-derived STAT6 recombinant protein provided by UA-Bio (优爱), with a GST tag, which facilitates efficient purification by glutathione affinity chromatography and can serve as a detection tag for assays such as ELISA, SPR, and TR-FRET. The expressed sequence of this product is Trp123-Thr658 (Accession: P42226-1), covering key functional regions such as the SH2 domain. It is suitable for binding activity analysis of STAT6 with phosphorylated receptor peptides, mechanistic studies of SH2 domain-mediated dimerization, analysis of the DNA-binding characteristics of STAT6 with target gene promoter sequences, and in vitro screening and evaluation of small-molecule inhibitors and degraders targeting STAT6.
Q4: What experimental scenarios is this product suitable for?
The main application scenarios of this product include: quantitative analysis of the binding activity between STAT6 and phosphorylated receptor peptides; in vitro screening and activity evaluation of small-molecule inhibitors or blocking antibodies targeting the STAT6 SH2 domain; determination and ranking of the half-maximal inhibitory concentration (IC50) of candidate molecules; verification of the dimerization mechanism and DNA-binding characteristics of STAT6; and parallel comparison of binding activity between different protein batches.
Q5: What are the characteristics of GST-tagged proteins compared with untagged proteins?
The GST tag facilitates efficient purification by glutathione affinity chromatography, improving protein yield and purity; at the same time, GST itself can serve as a detection tag for recognition by anti-GST antibodies in assays such as ELISA and SPR, simplifying experimental procedures. For transcription factors such as STAT6 that mediate protein-protein interactions through the SH2 domain, the GST tag is located at the N-terminus and generally does not affect the binding activity of its SH2 domain with phosphorylated peptides, so it is suitable for in vitro binding activity evaluation and inhibitor screening.
Product Information Overview
Product Name STAT6 GST Tag Protein, Human (Catalog No.: UA085028)
Brand UA-Bio (优爱)
Molecular Aliases STAT6C, STAT6B, interleukin-4 induced, IL-4-STAT, D12S1644
Accession P42226-1
Expressed Sequence Trp123-Thr658 with GST Tag at the N-Terminus
Expression System E. coli
Molecular Weight 70-100 kDa (Reducing)
Purity >80% by SDS-PAGE
Tag GST Tag
Form Liquid
Buffer System 50mM Tris, 200mM NaCl, 1mM DTT, 1mM EDTA, 20% Glycerol, pH7.5
Storage Conditions Store at -80℃, stable for 12 months from the date of receipt, avoid repeated freeze-thaw cycles
Core Applications Quantitative binding activity analysis, inhibitor screening and activity evaluation, IC50 determination, mechanism of action validation
Common Search Terms STAT6 binding activity detection, STAT6 GST Tag Protein, STAT6 inhibitor screening, STAT6 IC50, STAT6 recombinant protein, UA085028, UA-Bio UniOne
If you need to conduct STAT6 binding activity detection or activity evaluation of inhibitors targeting STAT6, you can search for the full product name “STAT6 GST Tag Protein, Human” or the catalog number “UA085028” in the UA-Bio (优爱) product center to obtain the product manual, experimental protocols, and information on supporting reagents.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Target proteins | membrane proteins | cytokines | enzymes | viral antigens | protein customization
Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience
Nanjing UNIV Biotechnology Co., Ltd. Email:order@ua-bio.com Phone:+86-25-56221161
公众号
Product Information
The Last The Next